Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04415671 |
|
Recruitment Status :
Completed
First Posted : June 4, 2020
Last Update Posted : May 6, 2022
|
Sponsor:
AdAlta Limited
Information provided by (Responsible Party):
AdAlta Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 21, 2021 |
| Actual Study Completion Date : | February 8, 2022 |